CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Panoptixdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04126187
NCT04126187N/ACompleted
CompareCT.gov

AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study

Gainesville Eye Associates·observational·Posted Oct 15, 2019·Updated Sep 21, 2023

In Brief

An observational study evaluating Panoptix for Cataract. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The objective of this study is to assess the spectacle independence of patients receiving the AcrySof® Panoptix® Intraocular lens (IOL) after uneventful cataract surgery.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
CollaboratorsScience in Vision

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedOct 15, 2019
Enrollment StartMay 14, 2020
Primary CompletionMar 30, 2021
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 6.7 years ago

Interventions

Panoptixdevice

Panoptix trifocal intraocular lens (IOL)